Max Robotics — Global Service Robot Directory + US Certification

About

Joseph Goodman is a surgeon-researcher whose work sits at the intersection of head and neck oncology and minimally invasive surgical innovation, with a particular focus on oropharyngeal squamous cell carcinoma (OPSCC). His most influential contribution, a 2021 comparative study of transoral robotic surgery (TORS) versus nonrobotic resection accumulating 28 citations, helped clarify the survival implications of robotic approaches for both HPV-positive and HPV-negative OPSCC patients. Recognizing that treatment-related morbidity — especially swallowing dysfunction — profoundly affects quality of life, Goodman has championed neoadjuvant chemotherapy combined with TORS as a strategy to reduce dependence on radiation while addressing the critical challenge of distant metastasis. His two-year swallowing outcomes study (12 citations) provided concrete functional evidence supporting this approach, and his ongoing phase II investigations continue to refine the protocol. Beyond oncologic strategy, Goodman demonstrates a practical ingenuity: his cost-effective custom dental guard for TORS reflects a commitment to making robotic surgery more accessible and reproducible. Collectively, his work — spanning roughly 64 cumulative citations — positions him as an emerging voice in surgical de-escalation strategies for HPV-related oropharyngeal cancer, offering patients effective tumor control with meaningfully reduced long-term toxicity.